Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular biology and evolution · doi:10.1093/molbev/mst197 · Cited by 41,174 · see citing works

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T. B., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,913 · see citing works

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure

Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405 · see citing works

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

Maldarelli, F., Wu, X., Su, L., Simonetti, F. R., Shao, W., Hill, S., Spindler, J., Ferris, A. L., Mellors, J. W., Kearney, M. F., et al. (2014) · Science · doi:10.1126/science.1254194 · Cited by 849 · see citing works

Defective proviruses rapidly accumulate during acute HIV-1 infection

Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737 · see citing works

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Folks, T. M., Clouse, K. A., Justement, J. S., Rabson, A. B., Duh, E. J., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 701 · see citing works

Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677 · see citing works

Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

Palmer, S., Kearney, M., Maldarelli, F., Halvas, E. K., Bixby, C. J., Bazmi, H., Rock, D., Falloon, J., Davey, R. T., Dewar, R. L., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.406-413.2005 · Cited by 506 · see citing works

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Dinoso, J. B., Kim, S. Y., Wiegand, A. P., Palmer, S., Gange, S. J., Cranmer, L. M., O'Shea, A., Callender, M., Spivak, A. M., Brennan, T. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 439 · see citing works

HIV-1 Integration Landscape during Latent and Active Infection

Cohn, L. B., da Silva, I. T., Oliveira, T. Y., Rosales, R., Parrish, E. H., Learn, G. H., Hahn, B. H., Czartoski, J., McElrath, M. J., Lehmann, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.020 · Cited by 438 · see citing works

Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 + T Cells

Bailey, J. R., Sedaghat, A. R., Kieffer, T. L., Brennan, T. P., Lee, P. K., Wind‐Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu‐Chittenden, Y., Lee, J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00591-06 · Cited by 417 · see citing works

Clonally expanded CD4 ⁺ T cells can produce infectious HIV-1 in vivo

Simonetti, F. R., Sobolewski, M. D., Fyne, E., Shao, W., Spindler, J., Hattori, J., Anderson, E. M., Watters, S. A., Hill, S., Wu, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522675113 · Cited by 372 · see citing works

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency

Pomerantz, R. J., Trono, D., Feinberg, M. B., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90691-7 · Cited by 365 · see citing works

Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy

Imamichi, H., Dewar, R. L., Adelsberger, J. W., Rehm, C. A., O’Doherty, U., Paxinos, E. E., Fauci, A. S., & Lane, H. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609057113 · Cited by 344 · see citing works

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

Gandhi, R. T., Zheng, L., Bosch, R. J., Chan, E. S., Margolis, D. M., Read, S., Kallungal, B., Palmer, S., Medvik, K., Lederman, M. M., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000321 · Cited by 305 · see citing works

B-108 Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

Maldarelli, F. M., Wu, X., Su, L., Simonetti, F. R., Wells, D. W., Shao, W., Spindler, J., Ferris, A. L., Mellors, J. W., Kearney, M. F., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000479721.09749.2d · Cited by 294 · see citing works

Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption

Rothenberger, M. K., Keele, B. F., Wietgrefe, S. W., Fletcher, C. V., Beilman, G. J., Chipman, J. G., Khoruts, A., Estes, J. D., Anderson, J. L., Callisto, S. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414926112 · Cited by 276 · see citing works

Defining HIV and SIV Reservoirs in Lymphoid Tissues

Deleage, C., Wietgrefe, S., Prete, G. D. D., Morcock, D. R., Hao, X.-P., Piatak, M., Bess, J., Anderson, J. L., Perkey, K. E., Reilly, C., et al. (2016) · Pathogens and Immunity · doi:10.20411/pai.v1i1.100 · Cited by 256 · see citing works

Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy

Kearney, M. F., Spindler, J., Shao, W., Yu, S. S., Anderson, E. M., O'Shea, A., Rehm, C. A., Poethke, C., Kovacs, N., Mellors, J. W., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004010 · Cited by 235 · see citing works

Immediate antiviral therapy appears to restrict resting CD4 + cell HIV-1 infection without accelerating the decay of latent infection

Archin, N. M., Vaidya, N. K., Kuruc, J. D., Liberty, A. L., Wiegand, A. P., Kearney, M. F., Cohen, M. S., Coffin, J. M., Bosch, R. J., Gay, C. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120248109 · Cited by 220 · see citing works

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

Besson, G. J., Lalama, C. M., Bosch, R. J., Gandhi, R. T., Bedison, M. A., Aga, E., Riddler, S. A., McMahon, D. K., Hong, F. F., & Mellors, J. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu585 · Cited by 217 · see citing works

Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals

Baxter, A. E., Niessl, J., Fromentin, R., Richard, J., Porichis, F., Charlebois, R., Massanella, M., Brassard, N., Alsahafi, N., Ortega-Delgado, G.-G., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.015 · Cited by 187 · see citing works

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA

Lorenzi, J. C. C., Cohen, Y. Z., Cohn, L. B., Kreider, E. F., Barton, J. P., Learn, G. H., Oliveira, T. Y., Lavine, C. L., Horwitz, J. A., Settler, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617789113 · Cited by 172 · see citing works

Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals

Kearney, M. F., Maldarelli, F. M., Shao, W., Margolick, J. B., Daar, E. S., Mellors, J. W., Rao, V. B., Coffin, J. M., & Palmer, S. (2008) · Journal of Virology · doi:10.1128/jvi.01960-08 · Cited by 170 · see citing works

The role of unintegrated DNA in HIV infection

Sloan, R. D., & Wainberg, M. A. (2011) · Retrovirology · doi:10.1186/1742-4690-8-52 · Cited by 155 · see citing works

Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy

Kearney, M. F., Wiegand, A. P., Shao, W., Coffin, J. M., Mellors, J. W., Lederman, M. M., Gandhi, R. T., Keele, B. F., & Li, J. Z. (2015) · Journal of Virology · doi:10.1128/jvi.02139-15 · Cited by 149 · see citing works

HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion

Maldarelli, F. M., Kearney, M. F., Palmer, S., Stephens, R. M., Mican, J. M., Polis, M. A., Davey, R. T., Kovacs, J. A., Shao, W., Rock-Kress, D., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01225-12 · Cited by 130 · see citing works

Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients Reveals that the Majority of CD4+ T-cells Contain One HIV-1 DNA Molecule

Josefsson, L., Palmer, S., Faria, N. R., Lemey, P., Casazza, J. P., Ambrozak, D. R., Kearney, M. F., Shao, W., Kottilil, S., Sneller, M. C., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003432 · Cited by 112 · see citing works

Improved Single-Copy Assays for Quantification of Persistent HIV-1 Viremia in Patients on Suppressive Antiretroviral Therapy

Cillo, A. R., Vagratian, D., Bedison, M. A., Anderson, E. M., Kearney, M. F., Fyne, E., Koontz, D. L., Coffin, J. M., Piatak, M., & Mellors, J. W. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02060-14 · Cited by 109 · see citing works

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy

Gandhi, R. T., Coombs, R. W., Chan, E. S., Bosch, R. J., Zheng, L., Margolis, D. M., Read, S., Kallungal, B., Chang, M., Goecker, E. A., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823fd1f2 · Cited by 107 · see citing works

Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA

Hong, F. F., Aga, E., Cillo, A. R., Yates, A. L., Besson, G. J., Fyne, E., Koontz, D. L., Jennings, C., Zheng, L., & Mellors, J. W. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02904-15 · Cited by 100 · see citing works

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

Kearney, M. F., Palmer, S., Maldarelli, F. M., Shao, W., Polis, M. A., Mican, J. M., Rock-Kress, D., Margolick, J. B., Coffin, J. M., & Mellors, J. W. (2008) · AIDS · doi:10.1097/qad.0b013e3282f29478 · Cited by 80 · see citing works

Accumulation and Intranuclear Distribution of Unintegrated Human Immunodeficiency Virus Type 1 DNA

Bell, P., Montaner, L. J., & Maul, G. G. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7683-7691.2001 · Cited by 63 · see citing works

Assays for precise quantification of total (including short) and elongated HIV-1 transcripts

Kaiser, P. D., Joshi, S. K., Kim, P., Li, P., Liu, H., Rice, A. P., Wong, J. K., & Yukl, S. A. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.12.017 · Cited by 40 · see citing works

Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy

Cillo, A. R., Krishnan, S., McMahon, D. K., Mitsuyasu, R. T., Para, M. F., & Mellors, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092118 · Cited by 29 · see citing works

Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy

Kearney, M. F., Anderson, E. M., Coomer, C. A., Smith, L., Shao, W., Johnson, N., Kline, C. E., Spindler, J., Mellors, J. W., Coffin, J. M., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0212-2 · Cited by 27 · see citing works

HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens

Kiselinova, M., Geretti, A. M., Malatinková, E., Vervisch, K., Beloukas, A. I., Messiaen, P., Bonczkowski, P., Trypsteen, W., Callens, S. F. J., Verhofstede, C., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv250 · Cited by 22 · see citing works

Unintegrated Circular HIV-1 DNA in the Peripheral Mononuclear Cells of HIV-1-Infected Subjects: Association With High Levels of Plasma HIV-1 RNA, Rapid Decline in CD4 Count, and Clinical Progression to AIDS

Panther, L., Coombs, R. W., Zeh, J. E., Collier, A. C., & Corey, L. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199804010-00003 · Cited by 22 · see citing works

Recent developments in human immunodeficiency virus-1 latency research

Chan, C. N., Dietrich, I., Hosie, M. J., & Willett, B. J. (2013) · Journal of General Virology · doi:10.1099/vir.0.049296-0 · Cited by 21 · see citing works

Quantifying the Turnover of Transcriptional Subclasses of HIV-1-Infected Cells

Althaus, C. L., Joos, B., Perelson, A. S., & Günthard, H. F. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003871 · Cited by 19 · see citing works

Tracking episomal HIV DNA

Sharkey, M. E. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835d08c2 · Cited by 10 · see citing works

Decay of Human Immunodeficiency Virus Type 1 Unintegrated DNA Containing Two Long Terminal Repeats in Infected Individuals after 3 to 8 Years of Sustained Control of Viremia

McDermott, J. L., Martini, I., Ferrari, D., Bertolotti, F., Giacomazzi, C., Murdaca, G., Puppo, F., Indiveri, F., & Varnier, O. E. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5272-5274.2005 · Cited by 10 · see citing works

Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus

Lau, J. W., Levy, D. N., & Wodarz, D. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.12.004 · Cited by 4 · see citing works

Molecular mechanism of HIV-1 resistance to 3′-azido-2′,3′-dideoxyguanosine

Meteer, J. D., Schinazi, R. F., Mellors, J. W., & Sluis‐Cremer, N. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.10.017 · Cited by 3 · see citing works

HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy

Ganor, Y., Real, F., Sennepin, A., Dutertre, C., Prevedel, L., Xu, L., Tudor, D., Muylder, B. C.-D., Couëdel-Courteille, A., Marion, S., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0335-z · Cited by 295 · see citing works

The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies

Cohn, L. B., Chomont, N., & Deeks, S. G. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.014 · Cited by 280 · see citing works

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

Einkauf, K. B., Osborn, M. R., Gao, C., Sun, W., Sun, X., Lian, X., Parsons, E. M., Gladkov, G. T., Seiger, K. W., Blackmer, J. E., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.011 · Cited by 260 · see citing works

Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion

Pinzone, M. R., VanBelzen, J., Weissman, S., Bertuccio, M. P., Cannon, L., Rullo, E. V., Migueles, S. A., Jones, R. B., Mota, T. M., Joseph, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08431-7 · Cited by 175 · see citing works

Why and where an HIV cure is needed and how it might be achieved

Ndung’u, T., McCune, J. M., & Deeks, S. G. (2019) · Nature · doi:10.1038/s41586-019-1841-8 · Cited by 144 · see citing works

HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

Halvas, E. K., Joseph, K. W., Brandt, L. D., Guo, S., Sobolewski, M. D., Jacobs, J. L., Tumiotto, C., Bui, J. K., Cyktor, J. C., Keele, B. F., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138099 · Cited by 141 · see citing works

Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells

Mukhamedova, N., Hoang, A., Dragoljevic, D., Dubrovsky, L., Pushkarsky, T., Low, H., Ditiatkovski, M., Fu, Y., Ohkawa, R., Meikle, P. J., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007907 · Cited by 132 · see citing works

Barriers and strategies to achieve a cure for HIV

Pitman, M. C., Lau, J. S. Y., McMahon, J. H., & Lewin, S. R. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30039-0 · Cited by 124 · see citing works

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile

García‐Broncano, P., Maddali, S., Einkauf, K. B., Jiang, C., Gao, C., Chevalier, J. M., Chowdhury, F. Z., Maswabi, K., Ajibola, G., Moyo, S. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7350 · Cited by 120 · see citing works

Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir

Mendoza, P., Jackson, J., Oliveira, T. Y., Gaebler, C., Ramos, V., Caskey, M. F., Janković, M., Nussenzweig, M. C., & Cohn, L. B. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200051 · Cited by 119 · see citing works

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

McManus, W. R., Bale, M. J., Spindler, J., Wiegand, A. P., Musick, A., Patro, S. C., Sobolewski, M. D., Musick, V. K., Anderson, E. M., Cyktor, J. C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126714 · Cited by 112 · see citing works

Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection

Leyre, L., Kroon, E. D. M. B., Vandergeeten, C., Sacdalan, C., Colby, D. J., Buranapraditkun, S., Schuetz, A., Chomchey, N., de Souza, M. S., Bakeman, W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav3491 · Cited by 108 · see citing works

Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency

Bradley, T., Ferrari, G., Haynes, B. F., Margolis, D. M., & Browne, E. P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.020 · Cited by 103 · see citing works

Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART

Gantner, P., Pagliuzza, A., Pardons, M., Ramgopal, M. N., Routy, J., Fromentin, R., & Chomont, N. (2020) · Nature Communications · doi:10.1038/s41467-020-17898-8 · Cited by 99 · see citing works

A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

Levy, C., Hughes, S. M., Roychoudhury, P., Reeves, D. B., Amstuz, C., Zhu, H., Huang, M.-L. W., Wei, Y., Bull, M. E., Cassidy, N. A. J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100243 · Cited by 94 · see citing works

The multifaceted nature of HIV latency

Dufour, C., Gantner, P., Fromentin, R., & Chomont, N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136227 · Cited by 94 · see citing works

Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART

Pasternak, A. O., Grijsen, M. L., Wit, F. W. N. M., Bakker, M. E., Jurriaans, S., Prins, J. M., & Berkhout, B. (2020) · JCI Insight · doi:10.1172/jci.insight.134196 · Cited by 92 · see citing works

Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy

White, J. A., Simonetti, F. R., Beg, S. A., McMyn, N. F., Dai, W., Bachmann, N., Lai, J., Ford, W. C., Bunch, C., Jones, J. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120326119 · Cited by 90 · see citing works

Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

White, J. A., Wu, F., Yasin, S., Moskovljevic, M., Varriale, J., Dragoni, F., Camilo-Contreras, A., Duan, J., Zheng, M. Y., Tadzong, N. F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165245 · Cited by 86 · see citing works

Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells

Dubé, M., Tastet, O., Dufour, C., Sannier, G., Brassard, N., Ortega-Delgado, G.-G., Pagliuzza, A., Richard, C., Nayrac, M., Routy, J., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.006 · Cited by 87 · see citing works

What do we measure when we measure cell-associated HIV RNA

Pasternak, A. O., & Berkhout, B. (2018) · Retrovirology · doi:10.1186/s12977-018-0397-2 · Cited by 86 · see citing works

Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines

McCauley, S. M., Kim, K., Nowosielska, A., Dauphin, A., Yurkovetskiy, L., Diehl, W. E., & Luban, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07753-2 · Cited by 78 · see citing works

Longitudinal study reveals HIV-1–infected CD4+ T cell dynamics during long-term antiretroviral therapy

Antar, A. A. R., Jenike, K. M., Jang, S., Rigau, D. N., Reeves, D. B., Hoh, R., Krone, M., Keruly, J. C., Moore, R. D., Schiffer, J. T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135953 · Cited by 81 · see citing works

HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers

Sharaf, R. R., Lee, G. Q., Sun, X., Etemad, B., Aboukhater, L. M., Hu, Z., Brumme, Z. L., Aga, E., Bosch, R. J., Wen, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120549 · Cited by 79 · see citing works

The forces driving clonal expansion of the HIV-1 latent reservoir

Liu, R., Simonetti, F. R., & Ho, Y. (2020) · Virology Journal · doi:10.1186/s12985-019-1276-8 · Cited by 74 · see citing works

No evidence of HIV replication in children on antiretroviral therapy

van Zyl, G. U., Katusiime, M. G., Wiegand, A. P., McManus, W. R., Bale, M. J., Halvas, E. K., Luke, B. T., Boltz, V. F., Spindler, J., Laughton, B., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94582 · Cited by 75 · see citing works

HIV evolution and diversity in ART-treated patients

van Zyl, G. U., Bale, M. J., & Kearney, M. F. (2018) · Retrovirology · doi:10.1186/s12977-018-0395-4 · Cited by 74 · see citing works

The role of integration and clonal expansion in HIV infection: live long and prosper

Anderson, E. M., & Maldarelli, F. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0448-8 · Cited by 72 · see citing works

Integrating Immunology and Microfluidics for Single Immune Cell Analysis

Sinha, N., Subedi, N., & Tel, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02373 · Cited by 71 · see citing works

Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir

Wang, Z., Simonetti, F. R., Siliciano, R. F., & Laird, G. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0404-7 · Cited by 67 · see citing works

HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs

Fromentin, R., & Chomont, N. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101438 · Cited by 67 · see citing works

Between a shock and a hard place: challenges and developments in HIV latency reversal

Zerbato, J. M., Purves, H. V., Lewin, S. R., & Rasmussen, T. A. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.03.004 · Cited by 68 · see citing works

New Frontiers in Measuring and Characterizing the HIV Reservoir

Falcinelli, S. D., Ceriani, C., Margolis, D. M., & Archin, N. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02878 · Cited by 62 · see citing works

The multifaceted nature of HIV latency

Dufour, C., Gantner, P., Fromentin, R., & Chomont, N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151380 · Cited by 63 · see citing works

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy

Singh, K., Natarajan, V., Dewar, R. L., Rupert, A. W., Badralmaa, Y., Zhai, T., Winchester, N., Scrimieri, F., Smith, M., Davis, I., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003667 · Cited by 60 · see citing works

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus

Musick, A., Spindler, J., Boritz, E., Pérez, L., Crespo-Vélez, D., Patro, S. C., Sobolewski, M. D., Bale, M. J., Reid, C., Keele, B. F., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02204 · Cited by 57 · see citing works

Immune Control of HIV

Balasubramaniam, M., Pandhare, J., & Dash, C. (2019) · JoLS Journal of Life Sciences · doi:10.36069/jols/20190603 · Cited by 53 · see citing works

Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors

Jefferys, S. R., Burgos, S. D., Peterson, J. J., Selitsky, S. R., Turner, A. W., James, L. I., Tsai, Y., Coffey, A. R., Margolis, D. M., Parker, J. S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009346 · Cited by 47 · see citing works

The cell biology of HIV-1 latency and rebound

Mbonye, U. R., & Karn, J. (2024) · Retrovirology · doi:10.1186/s12977-024-00639-w · Cited by 51 · see citing works

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

Zerbato, J. M., Khoury, G., Zhao, W. D., Gartner, M. J., Pascoe, R. D., Rhodes, A., Dantanarayana, A., Gooey, M., Anderson, J. L., Bacchetti, P., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103241 · Cited by 44 · see citing works

Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

Nathan L. Board, Yuan, Z., Wu, F., Moskovljevic, M., Ravi, M., Sengupta, S., Mun, S. S., Simonetti, F. R., Lai, J., Tebas, P., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01741-5 · Cited by 46 · see citing works

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms

Jacobs, J. L., Halvas, E. K., Tosiano, M. A., & Mellors, J. W. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02383 · Cited by 46 · see citing works

An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses

Wells, D., Guo, S., Shao, W., Bale, M. J., Coffin, J. M., Hughes, S. H., & Wu, X. (2020) · BMC Genomics · doi:10.1186/s12864-020-6647-4 · Cited by 45 · see citing works

Defective HIV-1 genomes and their potential impact on HIV pathogenesis

Kuniholm, J., Coote, C., & Henderson, A. J. (2022) · Retrovirology · doi:10.1186/s12977-022-00601-8 · Cited by 45 · see citing works

Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection

Lau, C., Adan, M. A., & Maldarelli, F. M. (2021) · Viruses · doi:10.3390/v13122512 · Cited by 44 · see citing works

HIV Reservoirs and Treatment Strategies toward Curing HIV Infection

Matsuda, K., & Maeda, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052621 · Cited by 43 · see citing works

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals

Wonderlich, E. R., Subramanian, K., Cox, B. D., Wiegand, A. P., Lackman-Smith, C., Bale, M. J., Stone, M., Hoh, R., Kearney, M. F., Maldarelli, F. M., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008074 · Cited by 42 · see citing works

CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency

Darcis, G., Kootstra, N. A., Hooibrink, B., van Montfort, T., Maurer, I., Groen, K., Jurriaans, S., Bakker, M. E., Lint, C. M. V., Berkhout, B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.071 · Cited by 43 · see citing works

Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy

Sun, C., Liu, L., Pérez, L., Li, X., Liu, Y., Xu, P., Boritz, E., Mullins, J. I., & Abate, A. R. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00864-8 · Cited by 43 · see citing works

Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses

Weymar, G. H. J., Bar‐On, Y., Oliveira, T. Y., Gaebler, C., Ramos, V., Hartweger, H., Breton, G., Caskey, M. F., Cohn, L. B., Janković, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111311 · Cited by 41 · see citing works

HIV integration sites and implications for maintenance of the reservoir

Symons, J., Cameron, P. U., & Lewin, S. R. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000438 · Cited by 41 · see citing works

Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans

Ferris, A. L., Wells, D. W., Guo, S., Prete, G. Q. D., Swanstrom, A. E., Coffin, J. M., Wu, X., Lifson, J. D., & Hughes, S. H. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007869 · Cited by 41 · see citing works

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections

Anderson, E. M., Simonetti, F. R., Gorelick, R. J., Hill, S., Gouzoulis, M. A., Bell, J., Rehm, C. A., Pérez, L., Boritz, E., Wu, X., et al. (2020) · Viruses · doi:10.3390/v12020136 · Cited by 41 · see citing works

Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques

Cadena, A. M., Ventura, J. D., Abbink, P., Borducchi, E. N., Tuyishime, H., Mercado, N. B., Walker-Sperling, V. E. K., Siamatu, M., Liu, P.-T., Chandrashekar, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21724-0 · Cited by 37 · see citing works

An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection

Lichterfeld, M. D., Gao, C., & Yu, X. G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.002 · Cited by 38 · see citing works

Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations

Hikichi, Y., Duyne, R. V., Pham, P., Groebner, J. L., Wiegand, A. P., Mellors, J. W., Kearney, M. F., & Freed, E. O. (2021) · mBio · doi:10.1128/mbio.03134-20 · Cited by 39 · see citing works

HIV persistence: silence or resistance?

Pasternak, A. O., & Berkhout, B. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101301 · Cited by 37 · see citing works

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART

Riddler, S. A., Zheng, L., Durand, C. M., Ritz, J., Koup, R. A., Ledgerwood, J. E., Bailer, R. T., Koletar, S. L., Eron, J. J., Keefer, M. C., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy242 · Cited by 37 · see citing works

Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities

León‐Rivera, R., Morsey, B., Niu, M., Fox, H. S., & Berman, J. W. (2020) · mBio · doi:10.1128/mbio.01037-20 · Cited by 33 · see citing works

Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4 + T Cells

Obregon-Perko, V., Bricker, K. M., Mensah, G., Uddin, F., Kumar, M. R., Fray, E. J., Siliciano, R. F., Schoof, N., Horner, A. M., Mavigner, M., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01669-20 · Cited by 33 · see citing works

IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus

Guney, M. H., Nagalekshmi, K., McCauley, S. M., Carbone, C., Aydemir, Ö., & Luban, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404349121 · Cited by 28 · see citing works

Next-generation bNAbs for HIV-1 cure strategies

Schriek, A. I., Aldon, Y., van Gils, M. J., & de Taeye, S. W. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105788 · Cited by 27 · see citing works

Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors

Jean, M. J., Fiches, G. N., Hayashi, T., & Zhu, J. K. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0153 · Cited by 29 · see citing works

Clonal Expansion of Infected CD4+ T Cells in People Living with HIV

Coffin, J. M., & Hughes, S. H. (2021) · Viruses · doi:10.3390/v13102078 · Cited by 24 · see citing works

Single-Cell Analysis Reveals Heterogeneity of Virus Infection, Pathogenicity, and Host Responses: HIV as a Pioneering Example

Brandt, L., Cristinelli, S., & Ciuffi, A. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-021820-102458 · Cited by 25 · see citing works

Persistent HIV-1 transcription during ART: time to reassess its significance?

Fombellida-Lopez, C., Berkhout, B., Darcis, G., & Pasternak, A. O. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000849 · Cited by 24 · see citing works

Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones

Dragoni, F., Kwaa, A. K., Traut, C. C., Veenhuis, R. T., Woldemeskel, B. A., Camilo-Contreras, A., Raymond, H. E., Dykema, A. G., Scully, E. P., Rosecrans, A. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171097 · Cited by 24 · see citing works

Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure

Khan, S., Telwatte, S., Trapečar, M., Yukl, S. A., & Sanjabi, S. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0153 · Cited by 24 · see citing works

Single-molecule techniques to quantify and genetically characterise persistent HIV

Wang, X. Q., & Palmer, S. (2018) · Retrovirology · doi:10.1186/s12977-017-0386-x · Cited by 23 · see citing works

Review

Bale, M. J., & Kearney, M. F. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000535 · Cited by 23 · see citing works

Detection of HPV E7 Transcription at Single-Cell Resolution in Epidermis

Lukowski, S. W., Tuong, Z. K., Nöske, K., Senabouth, A., Nguyen, Q. H., Andersen, S. B., Soyer, H. P., Frazer, I. H., & Powell, J. E. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.169 · Cited by 23 · see citing works

Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity

Sannier, G., Dubé, M., & Kaufmann, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00297 · Cited by 21 · see citing works

Latency Reversing Agents and the Road to an HIV Cure

Tioka, L., Diez, R. C., Sönnerborg, A., & van de Klundert, M. (2025) · Pathogens · doi:10.3390/pathogens14030232 · Cited by 20 · see citing works

Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy

Hong, F. F., Jacobs, J. L., Aga, E., Cillo, A. R., Fyne, E., Koontz, D. L., Zheng, L., & Mellors, J. W. (2018) · Virology · doi:10.1016/j.virol.2018.05.018 · Cited by 20 · see citing works

The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?

Pasternak, A. O., & Berkhout, B. (2021) · Viruses · doi:10.3390/v13091751 · Cited by 20 · see citing works

HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency

Crespo, R., Rao, S., & Mahmoudi, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.855092 · Cited by 19 · see citing works

The latent HIV reservoir: current advances in genetic sequencing approaches

Moar, P., Premeaux, T. A., Atkins, A., & Ndhlovu, L. C. (2023) · mBio · doi:10.1128/mbio.01344-23 · Cited by 19 · see citing works

Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy

Schwarzer, R., Gramatica, A., & Greene, W. C. (2020) · Viruses · doi:10.3390/v12020188 · Cited by 21 · see citing works

Structural and computational studies of HIV-1 RNA

Levintov, L., & Vashisth, H. (2023) · RNA Biology · doi:10.1080/15476286.2023.2289709 · Cited by 17 · see citing works

Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda

Joussef-Piña, S., Nankya, I., Nalukwago, S., Baseke, J., Rwambuya, S., Winner, D., Kyeyune, F., Chervenak, K. A., Thiel, B., Asaad, R. J., et al. (2022) · Retrovirology · doi:10.1186/s12977-022-00587-3 · Cited by 17 · see citing works

HIV-1 reservoir dynamics in CD4+ T cells

Bruner, K. M., & Cohn, L. B. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000521 · Cited by 15 · see citing works

Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption

Prator, C. A., Thanh, C., Kumar, S., Pan, T., Peluso, M. J., Bosch, R. J., Jones, N. G., Milush, J. M., Bakkour, S., Stone, M., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz572 · Cited by 16 · see citing works

Silencing the transcriptionally active HIV reservoir to improve treatment outcomes

Kazmierski, J., Tavora, R., O’Brien, R. L. F., Schulze‐Gahmen, U., Boehm, D., Roan, N. R., Nixon, D. F., Ndhlovu, L. C., Valente, S. T., & Ott, M. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01816-5 · Cited by 15 · see citing works

A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro

Matsuda, K., Islam, S., Takada, T., Tsuchiya, K., Tan, B. J. Y., Hattori, S.-I., Katsuya, H., Kitagawa, K., Kim, K. S., Matsuo, M., et al. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100122 · Cited by 15 · see citing works

HIV-1 activates oxidative phosphorylation in infected CD4 T cells in a human tonsil explant model

Swartz, T. H., Freeman, T., Zhao, C., Schrode, N., Beaumont, K. G., Tweel, B. C., Fortune, T., & Schroff, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172938 · Cited by 14 · see citing works

The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence

Astorga-Gamaza, A., & Buzón, M. J. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000685 · Cited by 14 · see citing works

HIV reservoir quantification by five-target multiplex droplet digital PCR

Levy, C., Hughes, S. M., Roychoudhury, P., Amstuz, C., Zhu, H., Huang, M.-L. W., Lehman, D. A., Jerome, K. R., & Hladik, F. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100885 · Cited by 14 · see citing works

Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy

Moskovljevic, M., Dragoni, F., Nathan L. Board, Wu, F., Lai, J., Zhang, H., White, J. R., Hoh, R., Lynn, K., Tebas, P., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.11.002 · Cited by 15 · see citing works

Strategies for an HIV cure: progress and challenges

Wang, F. S., Zhang, L., Douek, D. C., McMichael, A. J., Xu, X., & Lewin, S. R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0242-8 · Cited by 13 · see citing works

The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells

Copertino, D. C., Holmberg, C. S., Weiler, J., Ward, A. R., Howard, J. N., Levinger, C., Pang, A. P. S., Corley, M. J., Dündar, F., Zumbo, P., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.169028 · Cited by 12 · see citing works

Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption

Wang, X., & Xu, H. (2021) · Viruses · doi:10.3390/v13020335 · Cited by 12 · see citing works

An Evaluation on the Role of Non-Coding RNA in HIV Transcription and Latency: A Review

Ramirez, P. W., Pantoja, C., & Beliakova‐Bethell, N. (2023) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s383347 · Cited by 12 · see citing works

Protocol for high-throughput reservoir quantification across global HIV subtypes using a cross-subtype intact proviral DNA assay

Fish, C. S., Cassidy, N. A. J., Levy, C., Hughes, S. M., Jerome, K. R., Overbaugh, J. M., Hladik, F., & Lehman, D. A. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101681 · Cited by 11 · see citing works

Cell Size-Based Decision-Making of a Viral Gene Circuit

Bohn-Wippert, K., Tevonian, E. N., Lu, Y., Huang, M.-Y., Megaridis, M. R., & Dar, R. D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.009 · Cited by 11 · see citing works

Cure and Long-Term Remission Strategies

Mori, L., & Valente, S. T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1871-4_26 · Cited by 10 · see citing works

Challenges and Promise of Human Immunodeficiency Virus Remission

Li, Y., Mohammadi, A., & Li, J. Z. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa568 · Cited by 10 · see citing works

The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV

Karuppusamy, K. V., Babu, P., & Thangavel, S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10145-7 · Cited by 10 · see citing works

Genetically intact but functionally impaired HIV-1 env glycoproteins in the T-cell reservoir

de Verneuil, A., Migraine, J., Mammano, F., Molina, J.-M., Gallien, S., Mouquet, H., Hance, A. J., Clavel, F., & Dutrieux, J. (2018) · Journal of Virology · doi:10.1128/jvi.01684-17 · Cited by 10 · see citing works

Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth

Wang, X., Vincent, E., Siddiqui, S., Turnbull, K., Lü, H., Blair, R. V., Wu, X., Watkins, M., Ziani, W., Shao, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32554-z · Cited by 9 · see citing works

The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus

Joseph, S., Abrahams, M.-R., Moeser, M., Tyers, L., Archin, N. M., Sondgeroth, A., Spielvogel, E., Emery, A., Zhou, S., Doolabh, D., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011974 · Cited by 9 · see citing works

Characterizing HIV expression of proviruses during ART in tissues and blood

McManus, W. R., Bale, M. J., Musick, A., Spindler, J., Wiegand, A. P., Wu, X., Wells, D., Hughes, S. H., Keele, B. F., Hoh, R., et al. (2017) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30539-2

PP 3.2 – 00068 Differential transcriptional levels of HIV-1 near full-length and highly deleted proviruses

Nguyen, T. H. Y., Adams, L., Zipparo, M. E., Glassey, A., Santamaria, U., Rehm, C. A., Earhart, J., Shao, W., Lau, C. Y. L., & Maldarelli, F. M. (2022) · Journal of Virus Eradication · doi:10.1016/j.jve.2022.100182

A MAJORITY OF CLONALLY-EXPANDED T CELLS CONTAINING REPLICATION-COMPETENT HIV-1 PROVIRUSES ARE TRANSCRIPTIONALLY SILENT

Musick, A. (2019) · Maryland Shared Open Access Repository (USMAI Consortium) · doi:10.13016/m2otsv-zzxz

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus

Musick, A., Spindler, J., Boritz, E., Pérez, L., Crespo-Vélez, D., Patro, S. C., Sobolewski, M. D., Bale, M. J., Reid, C., Keele, B. F., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02204 · Cited by 57 · see citing works

INVESTIGATION OF HIV-1 ANTISENSE TRANSCRIPT EXPRESSION IN VIVO

Sklutuis, R. (2022) · Maryland Shared Open Access Repository (USMAI Consortium) · doi:10.13016/m2kwtv-j7gv